发明申请
- 专利标题： TETRACYCLIC CDK9 KINASE INHIBITORS
- 专利标题（中）： 四环素CDK9激酶抑制剂
-
申请号： US14568153申请日： 2014-12-12
-
公开(公告)号： US20150218165A1公开(公告)日： 2015-08-06
- 发明人: Robin Frey , Jianchun Gong , Zhiqin JI , Chunqiu Lai , Thomas Penning , Xiaohong Song , Andrew Souers , Yunsong Tong , Gui-Dong Zhu
- 申请人： AbbVie Inc.
- 申请人地址： US IL North Chicago
- 专利权人： ABBVIE INC.
- 当前专利权人： ABBVIE INC.
- 当前专利权人地址： US IL North Chicago
- 优先权： CNPCT/CN2014/071865 20140206
- 主分类号： C07D471/16
- IPC分类号： C07D471/16 ; A61K31/437 ; A61K31/55
摘要：
Disclosed are compounds of Formula (Ia), and pharmaceutically acceptable salts thereof, wherein X, Y, R1, R2, R3A, R3B, and R4 are as described herein. The compounds may be used as agents in the treatment of diseases, including cancer. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (Ia).
公开/授权文献
- US09328112B2 Tetracyclic CDK9 kinase inhibitors 公开/授权日：2016-05-03
信息查询
